| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/20/2011 | EP2310378A2 Oxadiazole-2-oxides as antischistosomal agents |
| 04/20/2011 | EP2310377A1 5-phenyl-isoxazole-3-carboxamides modulating hsp90 with antitumoral activities |
| 04/20/2011 | EP2310375A1 Chemical compounds |
| 04/20/2011 | EP2310374A1 Substituted 6- (1-piperazinyl) -pyridazines as 5-ht6 receptor antagonists |
| 04/20/2011 | EP2310373A1 Bicyclic heterocycles as mek kinase inhibitors |
| 04/20/2011 | EP2310372A2 Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| 04/20/2011 | EP2310371A2 Ppar agonist compounds and preparation and uses thereof for treating diabetes and/or dyslipidemia |
| 04/20/2011 | EP2310370A1 4, 6-diphenylpyrid-2-ones against cancer |
| 04/20/2011 | EP2310369A1 Benzyloxy anilide derivatives useful as potassium channel modulators |
| 04/20/2011 | EP2310368A1 Small molecule leptin receptor modulators |
| 04/20/2011 | EP2310366A2 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 04/20/2011 | EP2310364A1 Heterocyclic derivatives as hdac inhibitors |
| 04/20/2011 | EP2310363A2 Anticancer oral formulation |
| 04/20/2011 | EP2310359A1 Organic compounds |
| 04/20/2011 | EP2310357A1 Potassium ion channel modulators&uses thereof |
| 04/20/2011 | EP2310356A1 Adamantyl diamide derivatives and uses of same |
| 04/20/2011 | EP2310054A2 Aptamer inhibition of thrombus formation |
| 04/20/2011 | EP2310053A1 Pharmaceutical compositions comprising a complex of aminocyclohexane derivatives and cyclodextrin |
| 04/20/2011 | EP2310052A2 Acne treatment compositions comprising nanosilver and uses |
| 04/20/2011 | EP2310051A1 Combination of a parp inhibitor and an akt kinase activating compound |
| 04/20/2011 | EP2310050A1 Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of ras/raf/mek pathway |
| 04/20/2011 | EP2310039A1 Fgf-9 and its use relating to blood vessels |
| 04/20/2011 | EP2310031A1 Combination of a tiliroside and a peptide |
| 04/20/2011 | EP2310024A2 Estrogenic extracts for use in treating vaginal and vulvar atrophy |
| 04/20/2011 | EP2310021A2 Methods of using compositions comprising mir-192 and/or mir-215 for the treatment of cancer |
| 04/20/2011 | EP2310020A2 Novel acetates of 2-deoxy monosaccharides with anticancer activity |
| 04/20/2011 | EP2310019A2 5-ht3 receptor modulators, methods of making, and use thereof |
| 04/20/2011 | EP2310018A1 Use of nifurtimox for treating giardiasis |
| 04/20/2011 | EP2310017A1 Nifurtimox for treating diseases caused by trichomonadida |
| 04/20/2011 | EP2310016A1 Pde10 inhibitors and related compositions and methods |
| 04/20/2011 | EP2310015A1 Modulators of acetyl-coenzyme a carboxylase and methods of use thereof |
| 04/20/2011 | EP2310014A1 Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 04/20/2011 | EP2310013A1 Bicyclic triazole derivatives for treating tumors |
| 04/20/2011 | EP2310012A1 Process for the preparation of substituted pyrimidine derivatives |
| 04/20/2011 | EP2310011A2 Antineoplastic combinations containing hki-272 and vinorelbine |
| 04/20/2011 | EP2310010A2 Chemical compounds 251 |
| 04/20/2011 | EP2310009A2 Parenteral and oral formulations of benzimidazoles |
| 04/20/2011 | EP2310008A2 Ph specific solutions of sodium mycophenolic acid for the treatment of eye disorders |
| 04/20/2011 | EP2310007A2 Improving renal function with quercetin-containing compositions |
| 04/20/2011 | EP2310006A2 Treating cancer |
| 04/20/2011 | EP2310005A2 Treatment of inflammatory conditions with isothiocyanates |
| 04/20/2011 | EP2310004A1 Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of alzheimer's disease (ad) |
| 04/20/2011 | EP2310003A1 Inhibitors of carnitin-palmitoyl-transferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue |
| 04/20/2011 | EP2310002A1 Protective gel based on chitosan and oxidized polysaccharide |
| 04/20/2011 | EP2310001A2 Transdermal estrogen device and delivery |
| 04/20/2011 | EP2310000A1 Dermal delivery |
| 04/20/2011 | EP2309996A2 Amorphous ambrisentan |
| 04/20/2011 | EP2309995A1 Pharmaceutical formulation for lowering pulmonary blood pressure |
| 04/20/2011 | EP2309994A2 Sustained release pharmaceutical compositions comprising quetiapine |
| 04/20/2011 | EP2309991A2 Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same |
| 04/20/2011 | EP2309990A2 Drug loaded polymeric nanoparticles and methods of making and using same |
| 04/20/2011 | EP2309989A2 Drug loaded polymeric nanoparticles and methods of making and using same |
| 04/20/2011 | EP2309988A1 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms |
| 04/20/2011 | EP2309987A2 Melt granulation process |
| 04/20/2011 | EP2309984A2 Method of making a dry powder pharmaceutical composition |
| 04/20/2011 | EP2309983A2 Pharmaceutical form comprising tetrahydrobiopterin |
| 04/20/2011 | EP2309982A2 Controlled release copolymer formulation with improved release kinetics |
| 04/20/2011 | EP2309981A2 Dermatological composition that can be used in particular for the care and prevention of eschars |
| 04/20/2011 | EP2309980A1 Ophthalmic compositions for treating pathologies of the posterior segment of the eye |
| 04/20/2011 | EP2309978A1 Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof |
| 04/20/2011 | EP2309876A1 Nutritional composition containing oligosaccharide mixture |
| 04/20/2011 | EP2309860A1 Monocyclic cyanoenones and methods of use thereof |
| 04/20/2011 | EP2309859A1 Enzyme inhibitors and the use thereof |
| 04/20/2011 | EP2309858A1 Compositions and methods for treating inflammatory disorders |
| 04/20/2011 | EP2309856A1 Pharmaceutical compounds as cytotoxic agents and the use thereof |
| 04/20/2011 | EP2309854A1 Accelerated therapy |
| 04/20/2011 | EP2309853A1 Methods for regulating cell mitosis by inhibiting serine/threonine phosphatase |
| 04/20/2011 | EP2309852A1 Novel method |
| 04/20/2011 | EP2309849A1 Method of treating traumatic brain injury |
| 04/20/2011 | EP2227466B1 Heteroaryl-substituted piperidines |
| 04/20/2011 | EP2220070B1 2-benzylpyridazinone derivatives as met kinase inhibitors |
| 04/20/2011 | EP2217220B1 Lipoic acid pellet composition |
| 04/20/2011 | EP2124945B1 Method of providing pirfenidone therapy to a patient |
| 04/20/2011 | EP2121579B1 Malonamides as orexin antagonists |
| 04/20/2011 | EP2101781B1 Method for treating or preventing symptoms of hormonal variations |
| 04/20/2011 | EP2077293B1 Block copolymer for drug conjugates and their pharmaceutical compositions |
| 04/20/2011 | EP2061444B1 Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy |
| 04/20/2011 | EP2027082B1 12-aryl prostaglandin analogs |
| 04/20/2011 | EP2016081B1 Anti-viral pyrimidine nucleoside derivatives |
| 04/20/2011 | EP1976853B1 Novel compounds and use thereof |
| 04/20/2011 | EP1946752B1 Anti-allergic agent |
| 04/20/2011 | EP1933833B1 Therapy for the treatment of overactive bladder |
| 04/20/2011 | EP1928835B1 Alkyl sulfoxide quinolines as nk-3 receptor ligands |
| 04/20/2011 | EP1877384B1 Method for preparation of optionally 2-substituted 1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids |
| 04/20/2011 | EP1874312B1 Treatment of hpv induced anogenital intraepithelial neoplasia |
| 04/20/2011 | EP1859793B1 Novel combinational use of a sulfonamide compound in the treatment of cancer |
| 04/20/2011 | EP1845084B1 Process for producing (z)-1-phenyl-1-(n,n-diethylaminocarbonyl)idomethylcyclopropane |
| 04/20/2011 | EP1824975B9 Lna oligonucleotides and the treatment of cancer |
| 04/20/2011 | EP1784396B8 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors |
| 04/20/2011 | EP1781662B1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 04/20/2011 | EP1761533B1 1-aza-bicyclo[3.3.1]nonanes |
| 04/20/2011 | EP1750522B1 Use of pet food compositions |
| 04/20/2011 | EP1720872B1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors |
| 04/20/2011 | EP1718288B1 Solid formulations of ospemifene |
| 04/20/2011 | EP1699438B1 Pharmaceutical preparation containing gabapentin |
| 04/20/2011 | EP1680140B1 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 04/20/2011 | EP1647555B1 The c-glycosylisoflavones having alkylaminoalkoxyl substituent, the preparation and the use of the same |
| 04/20/2011 | EP1639141B1 Methods for treating lentivirus infections |
| 04/20/2011 | EP1625142B1 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein |
| 04/20/2011 | EP1603887B1 Hiv replication inhibiting indane substituted pyrimidines |